Pfizer strikes $43bn deal for cancer drug innovator Seagen

2 years ago

The pharmaceutical giant says it will pay $229 in cash for each share of Seagen. 

More Stories

CNBC Daily Open: Good news need not always be bad news for markets

31 mins ago

Britain seeks to build homegrown rival to OpenAI in bid to become world leader in artificial intelligence

3 hours ago

This 36-year-old sci-fi ‘nerd’ quit his banking job to start a deep space startup that has raised $24 million

3 hours ago

Leave a Reply

Your email address will not be published. Required fields are marked *

You may have missed

Love throws three picks as Packers exit playoffs to Eagles

31 mins ago

CNBC Daily Open: Good news need not always be bad news for markets

31 mins ago

Wrexham among Welsh EFL clubs to enter new cup with European access

3 hours ago

Britain seeks to build homegrown rival to OpenAI in bid to become world leader in artificial intelligence

3 hours ago

This 36-year-old sci-fi ‘nerd’ quit his banking job to start a deep space startup that has raised $24 million

3 hours ago